All News

The objective of the study was to determine whether atezolizumab could also be efficacious for patients with earlier-stage disease who may be at risk of disease recurrence following surgery

Pharmacy team members can provide educational resources, strategies to kids to promote safety.

Eating a lot of fat and sugar damage Paneth immune cells in the small intestine, which help regulate flora.

A recent study found that nearly 3% of insured adults in the United States under the age of 65 years take medications that weaken their immune system.

A study published in Nature may document a previously unknown interaction between gut microbes and the thymus, an immune system organ.

Physical changes to DNA may contribute to greater inflammation and fatigue for these individuals.

High antibody levels were also generated in participants with evidence of a prior SARS-CoV-2 infection, suggesting that this could be developed as a booster.

The combination of stress at work and at home has impacted the mental health of many women pharmacists during the COVID-19 pandemic.

Addressing the underlying causes of pharmacist burnout is essential, according to Melissa Santibañez, PharmD, BCCCP, a critical care clinical pharmacist at Memorial Regional Hospital.

Students at the Washington State University (WSU) College of Pharmacy and Pharmaceutical Sciences discussed opportunities at WSU that have been important stepping stones for their careers.

FDA approval of 2-drug injectable Cabenuva is a game changer in maintaining viral suppression in patients.

Occupational exposure to certain medications and long hours standing may increase risk.

The new data show that patients were able to benefit from finerenone treatment regardless of AFib history, which indicates that finerenone can reduce the rate of new-onset AFib.

Myriad issues are responsible, including lack of access and insurance and preexisting disadvantages in underserved populations.

The study authors sought to examine the risks of subsequent primary cancers (SPCs) among breast cancer survivors by HR status and age at diagnosis.

According to the study authors, this model provides insights into the multiscale biological alterations in the elderly and neurodegenerative brain, which have important implications for identifying treatment targets for Alzheimer disease.

Researchers found no evidence of abnormal blood flow between the mother and fetus or problems with fetal blood flow following COVID-19 vaccination.

Although there is no single playbook that works for all types of practices, some combinations of practice characteristics and operational changes can help practices address cardiovascular disease.

Guillermo Rodriguez Navarrete, the founder and CEO of Nutrillermo, and Elaine Ladd, the chief pharmacy officer of Pharmacy Development Services (PDS), discuss the value of the pharmacist in the health and wellness space for patients.

In a trial of amivantamab-vmjw, investigators found an overall response rate of 40% among patients with non-small cell lung cancer whose tumors have epidermal growth factor receptor exon 20 insertion mutations.

Pharmacy Times spoke with Lauren Simko, managing performance specialist at Pharmacy Development Services, about the future of lengthening the patient lifecycle and further developing pharmacy services.

Pharmacy Times spoke with Lauren Simko, managing performance specialist at Pharmacy Development Services, about how an improved patient experience goes hand-in-hand with lifecycle.

Pharmacy Times spoke with Lauren Simko, managing performance specialist at Pharmacy Development Services, about how elevating the patient experience can increase revenue for pharmacists in the healthcare space.

Guillermo Rodriguez Navarrete, the founder and CEO of Nutrillermo, and Elaine Ladd, the chief pharmacy officer of Pharmacy Development Services (PDS), discuss the role of social media in the health and wellness space.

The FDA has approved Verquvo (vericiguat; Merck) tablets for adults with chronic heart failure.

Ssatuximab (Sarclisa, Sanofi) is used in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma.

The investigators found that using the vaccine in combination with an immune checkpoint inhibitor—an established immunotherapy drug with a 20% success rate overall for patients—can vastly improve the proportion of individuals who respond to treatments, eliminating tumors in 75% of cases in mice.

Addition of atezolizumab and durvalumab to chemotherapy is a win for patients with extensive-stage small cell lung cancer

The safety profile for the combination treatment remained consistent with previously reported data in NSCLC and was deemed manageable with established protocols with no new safety signals identified.

Final data from a phase 3 trial assessing evolocumab in patients with HIV who have high cholesterol confirmed the safety and efficacy of the drug as a treatment.